EB-1A Green Card for Seattle's Extraordinary Researchers
The University of Washington's Institute for Protein Design — home to David Baker's 2024 Nobel Prize-winning computational protein design work — Fred Hutchinson Cancer Center's cancer immunotherapy programs, and the Allen Institutes make Seattle one of the country's most distinctive EB-1A metros. The self-petition structure is essential here: researchers move frequently between UW, Fred Hutch, the Allen Institutes, and Seattle's biotech sector — an approved EB-1A I-140 follows them across all of it.
Why Seattle's research base produces EB-1A records rapidly.
EB-1A requires sustained national or international acclaim — a standard that maps precisely to the research output expected of faculty and senior scientists at Seattle's major institutions. USCIS evaluates claims under eight criteria and requires at least three be satisfied, then applies a final merits determination requiring the totality of evidence shows the petitioner is among the small percentage at the very top of the field.
Seattle has an unusual concentration of research institutions whose work is internationally recognized across multiple distinct fields simultaneously. The University of Washington consistently ranks in the global top 10 in computer science, molecular biology, and public health — fields where EB-1A records develop through different criteria profiles but with similar depth. The Institute for Protein Design, built around David Baker's computational protein design methods (2024 Nobel Prize in Chemistry), is now one of the most globally recognized research groups in structural biology; researchers there build EB-1A records rapidly through original contributions that have enabled new biotechnology applications worldwide. Fred Hutchinson Cancer Center — where bone marrow transplantation was developed (1990 Nobel Prize) and where CAR-T and cancer immunotherapy research now leads nationally — provides another environment where EB-1A records develop at scale. The Allen Institute for Brain Science and Allen Institute for AI add research-nonprofit profiles where original contributions (the Allen Brain Atlas; open-source NLP tools) meet USCIS's most demanding criterion with strong independent evidence.
UW Institute for Protein Design
Led by David Baker (2024 Nobel Prize in Chemistry for computational protein design); researchers at the IDP whose work enables new therapeutics, vaccines, or biomaterials build EB-1A records through original contributions (protein design methods adopted by labs and companies worldwide), scholarly articles in Science, Nature, and Cell, and judging through NIH review panels; the Nobel-anchored institutional prestige supports the critical-role criterion at even early faculty stages.
Fred Hutchinson Cancer Center
Founded by E. Donnall Thomas (1990 Nobel Prize in Medicine for bone marrow transplantation); now a leading center for cancer immunotherapy, CAR-T therapy, and hematopoietic stem cell transplant; senior researchers publish in NEJM, JCI, Cancer Cell, and Nature Medicine; NCI Outstanding Investigator Awards, Parker Institute for Cancer Immunotherapy support, and NCI study section service are common criteria anchors.
UW Paul G. Allen School of Computer Science
Ranked in the global top 10 in computer science; faculty in systems, machine learning, programming languages, and HCI build EB-1A records through publications at SOSP, OSDI, NeurIPS, and PLDI; original contributions (widely-adopted systems, frameworks, or datasets) documented through GitHub metrics and citation counts; NSF CAREER and DARPA awards satisfy the prizes criterion.
UW Department of Genome Sciences
Globally recognized in whole-genome sequencing, single-cell transcriptomics, structural genomic variation, and spatial genomics; faculty publish as senior authors in Nature, Nature Genetics, Nature Methods, and Science; NIH NHGRI funding and study section service; genome sciences methods adopted globally satisfy the original-contributions criterion with citation analysis and expert letters from leading genomicists worldwide.
Allen Institute for Brain Science & AI
Allen Brain Science: creators of the Allen Brain Atlas (one of the most cited neuroscience resources in history); senior scientists qualify through original contributions (atlas methods adopted by the field), critical role at a recognized institution, and scholarly articles in Nature Neuroscience and Cell. Allen AI: senior research scientists with publications at NeurIPS, ACL, and ICLR and open-source frameworks (OLMo, Tulu, Semantic Scholar) with documented field-wide adoption.
Microsoft Research & senior tech scientists
Principal Researchers and Senior Principal Researchers at MSR who publish at top CS venues and whose open-source frameworks or research systems are adopted by the broader research community qualify for EB-1A through scholarly articles (top CS conference publications), judging (program committee service), and original contributions; high compensation at MSR also satisfies the salary criterion.
Eligibility criteria
The 8 EB-1A criteria for Seattle researchers.
At least 3 of 8 must be satisfied; USCIS then applies a final merits determination. Seattle researchers typically satisfy 4–6. The goal is well-documented evidence in the criteria most naturally supported by the petitioner's record — not a thin spread across all eight.
01 — PRIZES
Awards & prizes
NSF CAREER, NIH Pioneer or New Innovator Award, NCI Outstanding Investigator Award, Parker Institute for Cancer Immunotherapy awards, Burroughs Wellcome Fund awards; ACM or IEEE Fellow for CS; best paper awards at NeurIPS, ICML, or SOSP; AAAI best paper.
02 — MEMBERSHIP
Exclusive membership
National Academy of Sciences, National Academy of Medicine, National Academy of Engineering; ACM Fellow; IEEE Fellow; AAAI Fellow; AAAS Fellow; election to editorial boards requiring demonstrated expertise and peer selection.
03 — PRESS
Published material about the person
Wired, MIT Technology Review, Nature News, Science News, STAT News, The Scientist; coverage of protein design, genomics, or AI breakthroughs naming the researcher; Seattle Times science coverage; Bloomberg Technology or TechCrunch for industry-side researchers.
04 — JUDGING
Judging others' work
NIH or NSF review panels; NeurIPS, ICML, ICLR, ACL, or CVPR program committee; editorial board membership at Nature journals, Cell, JCI, or NEJM; NHGRI or NCI study section service; DARPA program evaluation.
05 — CONTRIBUTIONS
Original contributions of major significance
Protein design methods enabling new therapeutics or vaccines (documented through licensing and adoption); Allen Brain Atlas data resources adopted by thousands of labs; genomics pipelines used across the field; AI frameworks (GitHub stars + downstream citations); cancer immunotherapy protocols used at multiple centers.
06 — ARTICLES
Scholarly articles
Senior-author publications in Science, Nature, Cell, NEJM, Nature Medicine, Nature Genetics, Nature Nanotechnology, or top CS venues (NeurIPS, ICML, SOSP, PLDI, ACL) — with citation counts consistent with outstanding standing in the specific subspecialty.
07 — CRITICAL ROLE
Critical or essential role
Faculty at UW's IDP, Genome Sciences, or Allen School; senior scientists at Fred Hutch or Allen Institutes with independent research programs; Principal or Senior Principal Researchers at MSR with documented program leadership; all documented with institutional letters, org charts, and evidence of the institution's global standing.
08 — HIGH SALARY
High salary
More common for Microsoft Research scientists than for academic researchers; relevant for UW faculty with endowed chairs or joint industry-academic appointments; documented with AAUP, Radford, or Levels.fyi data showing compensation at or above the 90th percentile for the role and sector.
Seattle EB-1A profiles
What qualifying records look like here.
Representative profiles from Seattle EB-1A self-petitions. Identifying details have been generalized.
Research Scientist
UW Institute for Protein Design
De novo protein binders for cancer immunotherapy targets
18 publications; senior-author papers in Nature, Science, and Nature Chemical Biology
NIH R01 and Welch Foundation funding as PI
Protein design software licensed to 3 biotech companies
Invited speaker at AACR, ACS National Meeting, and EMBO
Self-petitioned without UW involvement. Criteria satisfied: original contributions (protein binders adopted by biotech companies and academic labs), scholarly articles, judging (NIH study section + 3 journals), critical role at the Nobel-anchored IDP. Expert letters from structural biologists and protein engineers worldwide documented the field-level adoption of the design methodology.
Associate Professor
Fred Hutchinson Cancer Center — Immunotherapy Integrated Research Center
Neoantigen-specific T cell responses and personalized cancer vaccines
24 publications; senior-author papers in Nature Medicine, JCI, and Cancer Cell
NCI R01 and Parker Institute for Cancer Immunotherapy grant
NCI study section standing member
AACR Translational Cancer Research Prize
Self-petitioned EB-1A without Fred Hutch's involvement. Criteria satisfied: prizes (AACR prize), scholarly articles, judging (NCI study section + 2 journals), original contributions (neoantigen identification approach adopted by 5+ cancer vaccine clinical trials). Strong final merits case given the depth of the record and Fred Hutch's institutional prestige.
Principal Researcher
Microsoft Research — Seattle
Large language model evaluation and reliability under distribution shift
16 publications at NeurIPS, ICML, and EMNLP; 4 papers each cited 200+
Creator of a widely used LLM evaluation benchmark (GitHub: 8K+ stars)
NeurIPS and ICLR program committee; invited talk at AAAI
Total compensation at 94th percentile per Radford
Self-petitioned EB-1A. Criteria satisfied: scholarly articles (top ML venues), contributions (benchmark adopted by 300+ papers and major AI labs), judging (program committee), high salary. Expert letters from leading ML academics documented the benchmark's role in standardizing evaluation across the field.
Choosing between pathways
EB-1A vs. NIW for Seattle researchers.
EB-1A and EB-2 NIW are the two self-petition green card paths available to Seattle researchers who are not being sponsored by their institution. The standards differ significantly. EB-1A requires sustained national or international acclaim — the very top of the field. NIW requires only that the proposed endeavor has substantial merit and national importance, that the petitioner is well-positioned, and that waiving PERM serves the national interest — a lower standard accessible earlier in a career.
For most postdocs and early-career researchers at UW, Fred Hutch, or the Allen Institutes, NIW is accessible before EB-1A is. The strategic move is to file NIW as soon as the record supports it — typically after several publications, a grant, and clear alignment with a national priority — to lock in a priority date. EB-1A is then filed later as the record matures. Both I-140s can be approved simultaneously. For Indian and Chinese nationals, early NIW filing is especially valuable for priority-date management — consult the Visa Bulletin. See the EB-1B Seattle page for the employer-sponsored alternative.
FAQ
Seattle EB-1A questions.
Yes. EB-1A is a self-petition — the I-140 is filed by or on behalf of the beneficiary with no employer signature, institutional approval, PERM, or job offer required. The University of Washington's international office is not involved unless UW separately decides to sponsor an EB-1B for the same person. The Institute for Protein Design, led by David Baker (2024 Nobel Prize in Chemistry), is recognized as a distinguished institution; researchers there build extraordinary ability records rapidly through original contributions, high-impact publications, and national recognition. Self-petition lets the researcher control their own green card timeline regardless of when UW decides to act on employer-sponsored sponsorship.
Fred Hutchinson Cancer Center — the institution where bone marrow transplantation was developed (1990 Nobel Prize) and now a leading center for cancer immunotherapy — provides strong EB-1A anchors. Critical role: faculty and senior scientists hold critical roles at a globally recognized cancer institution. Scholarly articles: publications in NEJM, JCI, Cancer Cell, and Nature Medicine as senior author. Judging: NCI study section service and editorial boards. Prizes: NCI Outstanding Investigator Award, Parker Institute for Cancer Immunotherapy awards. Original contributions: immunotherapy protocols or cellular therapy methods adopted at multiple centers. Expert letters from independent oncologists and immunologists at other leading centers are essential.
Microsoft Research scientists build EB-1A records on scholarly articles, judging, original contributions, and critical role. Scholarly articles: publications at NeurIPS, ICML, ICLR, SOSP, OSDI, or PLDI — USCIS has recognized these peer-reviewed conference publications as satisfying the scholarly articles criterion for computer scientists. Judging: program committee service for the same conferences, editorial board membership. Original contributions: research frameworks, algorithms, or systems adopted by the broader research community — documented through GitHub metrics, citation counts, and expert letters from academic CS faculty. Critical role: Principal Researcher at Microsoft Research is a critical role at a globally distinguished organization. High salary often satisfies the salary criterion.
UW Genome Sciences is consistently ranked among the world's top programs — it produced foundational work in whole-genome sequencing, single-cell transcriptomics, and structural genomic variation. Faculty whose work defines methods adopted by labs worldwide build EB-1A records through: original contributions (sequencing methods or computational genomics tools adopted broadly, documented through citation analysis and expert letters); scholarly articles (publications in Nature, Science, Nature Genetics, and Nature Methods as senior author); judging (NIH NHGRI study section service, editorial boards); and critical role (faculty at a recognized top-10 genomics program).
Yes. The Allen Institute for Brain Science (creator of the Allen Brain Atlas — one of the most cited neuroscience resources in history) and Allen Institute for AI (AI2) are well-recognized nonprofit research institutions. For Allen Brain Science senior scientists: critical role at a distinguished organization, scholarly articles in Nature Neuroscience and Cell, judging through peer review and grant panels. For AI2 senior research scientists: scholarly articles at NeurIPS, ICML, ACL, EMNLP, and ICLR; judging through program committee service; original contributions (open-source NLP frameworks and AI safety benchmarks) with documented adoption across the research community. Self-petition is the standard approach since Allen Institute immigration support is less established than at major universities.
